Cardioprotective potential of myricetin in isoproterenol-induced myocardial infarction in wistar rats

Phytotherapy Research

Volumn 23, Issue 10, 2009, Pages 1361-1366

  Tiwari, Roshan ^a   Mohan, Mahalaxmi ^a   Kasture, Sanjay ^a   Maxia, Andrea ^b   Ballero, Mauro ^b  

^a MGV's Pharmacy College   (India)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Antioxidant enzymes; Cardiac marker enzymes; ECG; Isoproterenol; Myricetin; Vascular reactivity

Indexed keywords

ADRENALIN; ASPARTATE AMINOTRANSFERASE; CATALASE; CREATINE KINASE; ISOPRENALINE; LACTATE DEHYDROGENASE; MYRICETIN; NORADRENALIN; PHENYLEPHRINE; SEROTONIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CELL INFILTRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SYNTHESIS; ELECTROCARDIOGRAPHY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; GRAPE; HEART INFARCTION; HEART PROTECTION; HEART RATE; HISTOPATHOLOGY; MALE; NONHUMAN; RAT; ST SEGMENT ELEVATION;

ANIMALS; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; CATALASE; CREATINE KINASE; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; FLAVONOIDS; HEART; HEART RATE; ISOPROTERENOL; L-LACTATE DEHYDROGENASE; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; PHYTOTHERAPY; PLANT EXTRACTS; PROTECTIVE AGENTS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; VITIS;

ANIMALIA; RATTUS; RATTUS NORVEGICUS; VITACEAE; VITIS VINIFERA;

EID: 70349921955     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2688     Document Type: Article

References (32)

1. Balaraman R, Hingorani N, Rathod SP. 1993. Studies on the antihypertensive effect of Abana in rats. Indian J Pharmacol 25: 209-214.
2. Beers RF JR, Sizer IW. 1952. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 115: 133-140.
3. Bergmeyer HU. 1974. Methods of Enzymatic Analysis, 2nd edn, Vol II. Academic Press: New York.
4. Das DK, Maulik N. 1995. Protection against free radical injury in the heart and cardiac performance. In Exercise and Oxygen Toxicity, Sen CK, Packer L, Hannineren O (eds). Elsevier Science: Amsterdam, 359-388.
5. Harborne JB. 2007. Phytochemical Methods - A Guide to Modern Techniques of Plant Analysis, 3rd edn. Springer (India) Private Limited: New Delhi, 75-76.
6. Holland RP, Brooks H. 1977. TQ-ST segment mapping: critical review and analysis of current concepts. Am J Cardiol 40: 110-129. (Pubitemid 8142270)
7. Kela AK, Reddy LP, Thombre DP. 1980. ECG findings in normal rats and after administration of isoproterenol. Indian J Physiol Pharmacol 24: 84-90.
8. King J. 1965. Practical Clinical Enzymology. D Van Nostrand Co. Ltd: London, 121.
9. Knufman NM, Van Der Laarse A, Vliegen HW, Brinkman CJ. 1987. Quantification of myocardial necrosis and cardiac hypertrophy in isoproterenol-treated rats. Res Commun Chem Pathol Pharmacol 57: 15-32.
10. Ko CH, Shen SC, Lee TJ, Chen YC. 2005. Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells. Mol Cancer Ther 4: 281-290.
11. Lie JT, Pairolero PC, Holley KE. 1975. Macroscopic enzyme mapping verification of large, homogenous, experimental myocardial infarcts of predictable size and location in dogs. J Thorac Cardiovasc Surg 69: 599-605.
12. Maroko PR, Libby P, Sobel BE et al. 1972. Effect of glucose-insulin- potassium infusion on myocardial infarction following experimental coronary artery occlusion. Circulation 45: 1160-1175.
13. Miller DD. 1991. Acute Myocardial Infarction. CLS Inc. Press: New York, 45-76.
14. Mira L, Fernandez MT, Santos M, Rocha R, Florencio MH, Jennings KR. 2002. Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radic Res 36: 1199-1208. (Pubitemid 35230240)
15. Nirmala C, Puvanakrishnan R. 1996. Effect of curcumin on certain lysosomal hydrolases in isoproterenol-induced myocardial infarction in rats. Biochem Pharmacol 51: 47-51. (Pubitemid 126333944)
16. Ono K, Nakane H, Fukushima M, Chermann JC, Barre Sinoussi F. 1990. Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. Eur J Biochem 190: 469-476.
17. Rajadurai M, Stanely Mainzen Prince P. 2006. Preventive effect of naringin on lipids, lipoproteins and lipid metabolic enzymes in isoproterenol-induced myocardial infarction in Wistar rats. J Biochem Mol Toxicol 228: 259-268.
18. Robak J, Shridi F, Wolbis M, Krolikowska M. 1988. Screening of the influence of flavonoids on lipoxygenase and cyclooxygenase activity, as well as on nonenzymic lipid oxidation. Pol J Pharmacol Pharm 40: 451-458.
19. Rusjan D, Zora K. 2007. A comparison of extraction methods for selected phenolic compounds from grape berry skins using liquid chromatography and spectrophotometry. Acta Chim Slov 54: 114-118.
20. Saggu H, Cooksey J, Dexter D. 1989. A selective increase in particulate superoxide dismutase activity in Parkinsonian substantia nigra. J Neurochem 53: 692-697.
21. Saravanan G, Prakash J. 2004. Effect of garlic (Allium sativum) on lipid peroxidant in experimental myocardial infarction in rats. J Ethnopharmacol 94: 155-158. (Pubitemid 38949817)
22. Satish V, Vimal V, Ebenezar KK, Devaki T. 2002. Synergistic effect of nicorandil and amlodipine on mitochondrial functions during isoproterenol- induced myocardial infarction in rats. J Pharm Pharmacol 54: 133-137. (Pubitemid 34116233)
23. Sharma M, Kishore K, Gupta SK, Joshi S, Arya D. 2001. Cardioprotective potential of Ocimum sanctum in isoproterenol induced myocardial infarction in rats. Mol Cell Biochem 225: 75-83. (Pubitemid 33014635)
24. Szasz G, Gruber W, Bernt E. 1976. Creatine kinase in serum: 1. Determination of optimum reaction conditions. Clin Chem 22: 650-656.
25. Thompson JA, Hess ML. 1986. The oxygen free radical system: a fundamental mechanism in the production of myocardial necrosis. Prog Cardiovasc Dis 28: 449-462.
26. Tokusoglu O, Unal MK, Yildirim Z. 2003. HPLC-UV and GC-MS characterization of the flavanol aglycones quercetin, kaempferol, and myricetin in tomato pastes and other tomato based products. Acta Chromatogr 13: 196-207.
27. Tzeng SH, Ko FN, Teng, CM. 1991. Inhibition of platelet aggregation by some flavonoids. Thromb Res 64: 91-100.
28. Vaage J, Valen G. 1993. Pathophysiology and mediators of ischemia reperfusion injury with special reference to cardiac surgery. Scand J Thorac Cardiovasc Surg 41: 1-18.
29. Wexler BC. 1978. Myocardial infarction in young vs old male rats; pathophysiologic changes. Am Heart J 96: 70-80. (Pubitemid 8378086)
30. Whealthy AM, Thandroyen FT, Opie LH. 1985. Catecholamine induced myocardial cell damage: catecholamines or adrenochrome. J Mol Cell Cardiol 17: 379-1359
31. Yates JC, Beamish RE, Dhalla NS. 1981. Ventricular dysfunction and necrosis produced by adrenochrome metabolite of epinephrine: relation to pathogenesis of catecholamine cardiomyopathy. Am Heart J 102: 210-221.
32. Yates JC, Dhalla NS. 1975. Induction of necrosis and failure in the isolated perfused rat heart with oxidized isoproterenol. J Mol Cell Cardiol 7: 807-816.